Berton G, Bewersdorf JP, Gilhodes J, Iat A, Soua A, DeAngelo DJ, Boussi L, Shallis RM, Žučenka A, Bystrom RP, Ling K, Aguirre LE, Stone RM, Luskin MR, Garcia JS, Winer ES, Chen EC, Wadleigh M, Mendez L, Podoltsev N, Tauveron-Jalenques U, Lanino L, Stein E, Zeidan AM, Forcade E, Cluzeau T, Dumas P-Y, Heiblig M, Devillier R, Shimony S, Goldberg AD, Stahl M, Garciaz S. Hypomethylating agents plus venetoclax versus intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia. haematol [Internet]. 2020Sep.10 [cited 2026Apr.9];. Available from: https://haematologica.org/article/view/13438